Completed NA INTERVENTIONAL 1-arm NCT01256502

The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery

Sponsor: Sofregen Medical, Inc.

Updated 8 times since 2017 Last updated: Oct 5, 2017 Started: Oct 31, 2010 Primary completion: Oct 31, 2012 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Breast Reconstruction and is currently completed. Sofregen Medical, Inc. leads this study, which shows 8 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Dec 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 3 earlier versions

Dec 2017 — Jun 2018 [monthly]

Completed NA
Feb 2017 — Dec 2017 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sofregen Medical, Inc.

Data source: Sofregen Medical, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States